Phase Ib trial of inhaled iloprost for the prevention of lung cancer with predictive and response biomarker assessment.

Saved in:
Bibliographic Details
Title: Phase Ib trial of inhaled iloprost for the prevention of lung cancer with predictive and response biomarker assessment.
Authors: Miller YE; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Aurora, CO, United States.; Pulmonary and Critical Care Section, RMR VAMC Rocky Mountain Regional Veteran Administration Medical Center, Aurora, CO, United States., Ghosh M; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Aurora, CO, United States., Merrick DT; Department of Pathology, University of Colorado, Aurora, CO, United States., Kubala B; Cancer Center Clinical Trial Core, University of Colorado, Aurora, CO, United States., Szabo E; Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, United States., Bengtson L; Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, United States., Kocherginsky M; Department of Preventative Medicine, Northwestern University, Evanston, IL, United States., Helenowski IB; Department of Preventative Medicine, Northwestern University, Evanston, IL, United States., Benante K; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Evanston, IL, United States., Schering T; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Evanston, IL, United States., Kim J; Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, United States., Kim H; Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH, United States., Ha D; Pulmonary and Critical Care Section, RMR VAMC Rocky Mountain Regional Veteran Administration Medical Center, Aurora, CO, United States., Bergan RC; Fred and Pamela Buffett Cancer Center, Division of Oncology & Hematology, Genitourinary Oncology, University of Nebraska, Evanston, IL, United States., Khan SA; Department of Surgery, Northwestern University, Omaha, NE, United States., Keith RL; Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Aurora, CO, United States.; Pulmonary and Critical Care Section, RMR VAMC Rocky Mountain Regional Veteran Administration Medical Center, Aurora, CO, United States.
Source: Frontiers in oncology [Front Oncol] 2023 Aug 30; Vol. 13, pp. 1204726. Date of Electronic Publication: 2023 Aug 30 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2234-943X
DOI:10.3389/fonc.2023.1204726